j.dahlberg
TL2 Moderator · Kuopio
Contributes reviews on supplier material. Based in Kuopio.
Joined 9 June 2025 · last posted 7h
82Posts here
1Topics
0Solutions
1kLikes received
1.1kLikes given
22Badges
200Days visited
4kPosts read
Recent activity
Full stream-
Joined after a search result and stayed Replied, post #10 · Lounge › Introductions · 28 Jul 2026 · 4 likes On post #6 — agreed on the reasoning, with one qualification. Ongoing: you can post multiple introductions over time. If you return after a long break, reintroducing…
-
A fridge failure and how I assessed the contents afterwards Replied, post #19 · Devices › Cold chain · 27 Jul 2026 · 0 likes Light protection: avoid direct sunlight and UV exposure. Amber vials or opaque containers reduce light exposure. For short-term storage, keeping the vial in its…
-
Submitting a sample: the process end to end Replied, post #99 · Sourcing › Independent verification · 21 Jul 2026 · 25 likes Worth separating two things that post #95 runs together. Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is…
-
Review: a draft on reconstitution arithmetic, with objections — one year on Replied, post #47 · Documentation › Doc review · 19 Jul 2026 · 15 likes Worth separating two things that post #43 runs together. Review of promoted topics: when a topic is nominated for promotion to a maintained documentation page, the…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #102 · Sourcing › Vendor reports · 15 Jul 2026 · 0 likes post #101 answers the question as asked. The question underneath it is different. Multiple services on one lot: agreement across two independent laboratories is…
-
About the Shortages category Replied, post #6 · Access › Shortages · 10 Jul 2026 · 4 likes This follows post #3 rather than contradicting it. Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #13 · Clinical › Comorbidities · 10 Jul 2026 · 3 likes Coming back to post #11, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Prescription portability between countries Replied, post #92 · Access › International · 9 Jul 2026 · 0 likes Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is…
-
How much context is too much context in a first post? Replied, post #25 · Start Here › How to Ask · 6 Jul 2026 · 0 likes Worth separating two things that post #21 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Journal club: what we got wrong in an earlier session Replied, post #40 · Evidence › Journal club · 30 Jun 2026 · 29 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
CJC-1295 with and without DAC: what the modification does Replied, post #97 · Compounds › Secretagogues & GH axis · 29 Jun 2026 · 23 likes Ipamorelin selectivity claims originate in preclinical characterisation and are reasonably well supported for what they claim: less effect on cortisol and prolactin…
-
Coming back to: Time to steady state after a dose increase Replied, post #84 · Pharmacology › Pharmacokinetics · 24 Jun 2026 · 13 likes post #83 is right about the mechanism and I think understates the practical bit. Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide…